NDC Package 51662-1551-3 Lidocaine Hydrochloride

Jelly Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51662-1551-3
Package Description:
25 POUCH in 1 CASE / 1 VIAL, SINGLE-USE in 1 POUCH (51662-1551-2) / 20 mL in 1 VIAL, SINGLE-USE
Product Code:
Proprietary Name:
Lidocaine Hydrochloride
Non-Proprietary Name:
Lidocaine Hydrochloride
Substance Name:
Lidocaine Hydrochloride
Usage Information:
Lidocaine Hydrochloride Jelly USP, 2% is indicated for prevention and control of pain in procedures involving the male and female urethra for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation (oral and nasal).
11-Digit NDC Billing Format:
51662155103
NDC to RxNorm Crosswalk:
  • RxCUI: 1011852 - lidocaine HCl 2 % Topical Gel
  • RxCUI: 1011852 - lidocaine hydrochloride 0.02 MG/MG Topical Gel
  • RxCUI: 1011852 - lidocaine hydrochloride 2 % Topical Jelly
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hf Acquisition Co Llc, Dba Healthfirst
    Dosage Form:
    Jelly - A class of gels, which are semisolid systems that consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA086283
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    06-14-2021
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51662-1551-3?

    The NDC Packaged Code 51662-1551-3 is assigned to a package of 25 pouch in 1 case / 1 vial, single-use in 1 pouch (51662-1551-2) / 20 ml in 1 vial, single-use of Lidocaine Hydrochloride, a human prescription drug labeled by Hf Acquisition Co Llc, Dba Healthfirst. The product's dosage form is jelly and is administered via topical form.

    Is NDC 51662-1551 included in the NDC Directory?

    Yes, Lidocaine Hydrochloride with product code 51662-1551 is active and included in the NDC Directory. The product was first marketed by Hf Acquisition Co Llc, Dba Healthfirst on June 14, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 51662-1551-3?

    The 11-digit format is 51662155103. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151662-1551-35-4-251662-1551-03